Benzodiazepine-Related Cognitive Impairment or Dementia: A Signal Detection Study Using a Case/Non-Case Approach
4
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Objective The association between benzodiazepine use and the risk of cognitive impairment or dementia has been controversial. Our study aims to detect this association through a case/non-case method using the Korea Institute of Drug Safety & Risk Management-Korea adverse event reporting system database (KIDS-KD) between 2007 and 2016.Methods Cases were adverse event (AE)-pairs with suspected cognitive impairment or dementia. 10 non-cases were matched to each case on age and sex. Exposure was defined as use of benzodiazepines, including long-, intermediate-, and short-acting benzodiazepine. We conducted multivariable logistic regression analyses to estimate reporting odds ratios (ROR) and 95% confidence intervals (CI).Results Of the 1,086,584 AE-pairs, 887 cases were suspected AE-pairs of cognitive impairment or dementia, and 775,444 non-cases were selected. Benzodiazepine use was associated with increased AE-pairs of cognitive impairment or dementia when assessed using those with certain, probable, and/or possible in causality assessments (ROR=2.69, 95% CI=1.66–4.38). Higher ROR estimates were shown in female (2.33, 1.48–3.67) and in those with polypharmacy (2.20, 1.35–3.57). Dementia safety profiles were inconsistent across individual benzodiazepine components.Conclusion These results suggest the potentially increased association between benzodiazepine use and cognitive impairment or dementia in female and those with polypharmacy. Inconsistent safety profiles of benzodiazepine components should be further investigated.
Abstract
Objective The association between benzodiazepine use and the risk of cognitive impairment or dementia has been controversial. Our study aims to detect this association through a case/non-case method using the Korea Institute of Drug Safety & Risk Management-Korea adverse event reporting system database (KIDS-KD) between 2007 and 2016.Methods Cases were adverse event (AE)-pairs with suspected cognitive impairment or dementia. 10 non-cases were matched to each case on age and sex. Exposure was defined as use of benzodiazepines, including long-, intermediate-, and short-acting benzodiazepine. We conducted multivariable logistic regression analyses to estimate reporting odds ratios (ROR) and 95% confidence intervals (CI).Results Of the 1,086,584 AE-pairs, 887 cases were suspected AE-pairs of cognitive impairment or dementia, and 775,444 non-cases were selected. Benzodiazepine use was associated with increased AE-pairs of cognitive impairment or dementia when assessed using those with certain, probable, and/or possible in causality assessments (ROR=2.69, 95% CI=1.66–4.38). Higher ROR estimates were shown in female (2.33, 1.48–3.67) and in those with polypharmacy (2.20, 1.35–3.57). Dementia safety profiles were inconsistent across individual benzodiazepine components.Conclusion These results suggest the potentially increased association between benzodiazepine use and cognitive impairment or dementia in female and those with polypharmacy. Inconsistent safety profiles of benzodiazepine components should be further investigated.
참고문헌 (39)
- Anttila T, "Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age : a prospective population based study", BMJ Brit Med J, 329, pp.539~ (2004)
- Donoghue J, "Usage of benzodiazepines : a review", Int J Psychiatry Clin, 14, pp.78~87 (2010)
- Gray SL, "Benzodiazepine use and risk of incident dementia or cognitive decline : prospective population based study", BMJ Brit Med J, 352, pp.i90~ (2016)
- Billioti de Gage S, "Benzodiazepine use and risk of dementia: prospective population based study", BMJ Brit Med J, 345, pp.e6231~ (2012)
- Billioti de Gage S, "Benzodiazepine use and risk of Alzheimer’s disease: case-control study", BMJ, 349, pp.g5205~ (2014)
- Puustinen J, "CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged : a longitudinal population-based study", Dement Geriatr Cogn Dis Extra, 2, pp.57~68 (2012)
- Azad NA, "Gender differences in dementia risk factors", Gender Med, 4, pp.120~129 (2007)
- van der Flier WM, "Epidemiology and risk factors of dementia", J Neurol Neurosur Psychiatry, 76(Suppl 5), pp.v2~v7 (2005)
- Lai SW, "Association between polypharmacy and dementia in older people : a population-based casecontrol study in Taiwan", Geriatr Gerontol Int, 12, pp.491~498 (2012)
- Takada M, "Association between benzodiazepine use and dementia : data mining of different medical databases", Int J Med Sci, 13, pp.825~834 (2016)
- Islam MM, "Benzodiazepine use and risk of dementia in the elderly population : a systematic review and meta-analysis", Neuroepidemiology, 47, pp.181~191 (2016)
- Grande G, "Use of benzodiazepines and cognitive performance in primary care patients with first cognitive complaints", Int Psychogeriatr, 30, pp.597~601 (2018)
- Montastruc JL, "Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database", Br J Clin Pharmacol, 72, pp.905~908 (2011)
- Chavant F, "Memory disorders associated with consumption of drugs : updating through a case", noncase study in the French PharmacoVigilance Database, 2011, pp.72, 898~904
- Shin JY, "New initiatives for pharmacovigilance in South Korea : introducing the Korea Institute of Drug Safety and Risk Management(KIDS)", Pharmacoepidemiol Drug Saf, 23, pp.1115~1122 (2014)
- Egberts AC, "Non-puerperal lactation associated with antidepressant drug use", Br J Clin Pharmacol, 44, pp.277~281 (1997)
- Egberts AC, "Use of measures of disproportionality in pharmacovigilance : three Dutch examples", Drug Saf, 25, pp.453~458 (2002)
- Stricker BH, "Serum sickness-like reactions to cefaclor", J Clin Epidemiol, 45, pp.1177~1184 (1992)
- Estivill E, "Consensus on drug treatment, definition and diagnosis for insomnia", Clin Drug Investig, 23, pp.351~385 (2003)
- Nomura K, "Regular prescriptions for benzodiazepines : a cross-sectional study of outpatients at a university hospital", Intern Med, 45, pp.1279~1283 (2006)
- Murayama H, "Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice : the Japan Adverse Drug Events Study", Pharmacol Res Perspect, 6 (2018)
- Haider SI, "Trends in polypharmacy and potential drug-drug interactions across educational groups in elderly patients in Sweden for the period 1992-2002", Int J Clin Pharmacol Ther, 45, pp.643~653 (2007)
- Altamura AC, "Understanding the pharmacokinetics of anxiolytic drugs", Expert Opin Drug Metab Toxicol, 9, pp.423~440 (2013)
- Moride Y, "Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research", J Clin Epidemiol, 47, pp.731~737 (1994)
- Stranks EK, "The acute cognitive effects of zopiclone, zolpidem, zaleplon, and eszopiclone : a systematic review and meta-analysis", J Clin Exp Neuropsychol, 36, pp.691~700 (2014)
- Tannenbaum C, "A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs", Drugs Aging, 29, pp.639~658 (2012)
- Hutchinson MA, "The behavioural and neuronal effects of the chronic administration of benzodiazepine anxiolytic and hypnotic drugs", Prog Neurobiol, 49, pp.73~97 (1996)
- Limon A, "Loss of functional GABA(A)receptors in the Alzheimer diseased brain", Proc Natl Acad Sci USA, 109, pp.10071~10076 (2012)
- Jo S, "GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease", Nat Med, 20, pp.886~896 (2014)
- Lagnaoui R, "Benzodiazepine use and risk of dementia : a nested case-control study", J Clin Epidemiol, 55, pp.314~318 (2002)
- Wu CS, "The association between dementia and long-term use of benzodiazepine in the elderly : nested case-control study using claims data", Am J Geriat Psychiatry, 17, pp.614~620 (2009)
- Shash D, "Benzodiazepine, psychotropic medication, and dementia : A population-based cohort study", Alzheimers Dement, 12, pp.604~613 (2016)
- Baek YH, "Uncertain Association Between Benzodiazepine Use and the Risk of Dementia : A Cohort Study", J Am Med Dir Assoc, 21, pp.201~211.e202 (2020)
- Beydoun MA, "Epidemiologic studies of modifiable factors associated with cognition and dementia : systematic review and meta-analysis", BMC Public Health, 14, pp.643~ (2014)
- Whitmer RA, "Obesity in middle age and future risk of dementia : a 27 year longitudinal population based study", BMJ, 330, pp.1360~ (2005)
- Cai L, "Schizophrenia and risk of dementia : a meta-analysis study", Neuropsychiatr Dis Treat, 14, pp.2047~2055 (2018)
- 구본대, "한국형 치매임상진료지침 소개", 대한의사협회지, 54(8), pp.861~875 (2011), 대한의사협회
- Taragano FE, "Mild behavioral impairment : a prodromal stage of dementia", Dement Neuropsychol, 2, pp.256~260 (2008)
- Rocca WA, "Trends in the incidence and prevalence of Alzheimer’s disease, dementia, and cognitive impairment in the United States", Alzheimers Dement, 7, pp.80~93 (2011)